Chemours shares shed $3.34 in a single session after a cut to 2026 earnings guidance. The lawsuit alleges that management overstated Opteon aftermarket demand while an oversupplied refrigerant channel weighed on sales.

NEW YORK, Oct. 28, 2026 /PRNewswire/ — Levi & Korsinsky, LLP alerts investors in The Chemours Company (NYSE: CC) of a pending securities class action. Class Period: February 20, 2026 through August 4, 2026. Find out if you may qualify to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Chemours shares fell $3.34, or 18.63%, to close at $14.59 on August 5, 2026. That erased nearly a fifth of the stock’s value in one trading session, after the Company cut its full-year adjusted EBITDA outlook from $800 million to $900 million down to $775 million to $825 million. To be considered for lead plaintiff, investors must file by December 7, 2026.

The August 5 Sell-Off by the Numbers

• Starting point: The stock had an implied closing price of about $17.93 on August 4, 2026, the final day of the Class Period.
• Single-session loss: Shares fell $3.34 per share, or 18.63%, to close at $14.59.
• Guidance trigger: The midpoint of the 2026 adjusted EBITDA outlook moved from $850 million to $800 million, a reduction of roughly 6%. The top of the range fell by $75 million.
• Quarterly results: Second quarter 2026 net sales were $1.6 billion, down approximately 1% year over year. The Company attributed the decline to a 4% decrease in volumes.
• Price target cuts: Between August 10 and August 13, 2026, three brokerage firms cut their price targets by 14.3% to 37.9%. The lowest new target was $15.

Why a Roughly 6% Outlook Trim Allegedly Fueled an 18.63% Drop

The complaint charges that throughout the Class Period, management described aftermarket demand for Opteon refrigerants as strong. Management also reaffirmed the full-year outlook as recently as May 2026. In its August 4 report, however, the Company tied lower volumes to a comparison with “elevated demand” in the prior-year quarter, which it said was driven by the “initial aftermarket channel fill” under the U.S. AIM Act.

As averred in the pleading, that aftermarket demand had been overstated, and the 2026 guidance was unreliable as a result. Brokerage commentary cited in the complaint pointed to a shift in earnings mix away from the higher-multiple Thermal & Specialized Solutions segment. One firm called that segment’s revenue contraction “a surprise to the market.”

“Chemours shareholders absorbed a loss of $3.34 per share in one session, a decline far steeper than the trim to the Company’s earnings outlook would suggest on its face. The complaint alleges that the share price reflected aftermarket demand that did not match what investors were told, and we are examining whether Class Period purchasers may seek to recover.” — Joseph E. Levi, Esq.

Submit your information here or call (212) 363-7500.

ABOUT THE FIRM — For over two decades, Levi & Korsinsky has represented shareholders in securities class actions. Ranked in ISS Top 50 for seven consecutive years. Investors who suffered losses have until December 7, 2026 to seek appointment as lead plaintiff.

Frequently Asked Questions About the CC Lawsuit

Q: Who are the defendants named in the CC lawsuit? A: The complaint names The Chemours Company and individual defendants including senior executives who signed SEC filings, made public statements, or certified financial disclosures under Sarbanes-Oxley.

Q: What is the CC class action lawsuit about? A: A securities class action has been filed against The Chemours Company (NYSE: CC) alleging materially false and misleading statements between February 20, 2026 and August 4, 2026. Shares fell approximately 18.63% after the Company disclosed a reduced full-year 2026 adjusted EBITDA outlook and lower Opteon aftermarket refrigerant sales tied to an earlier channel fill. Investors who purchased shares during the Class Period and suffered losses may be eligible to seek compensation.

Q: Who is eligible to join the CC investor lawsuit? A: Investors who purchased CC stock or securities between February 20, 2026 and August 4, 2026 and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.

Q: What do CC investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible as an absent class member.

Q: What if I already sold my CC shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.

Q: What if my CC losses are small — is it still worth contacting a lawyer? A: Yes. There is no minimum loss amount required to participate as a class member.

Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in the securities class action, they are generally handled on a contingency basis, with any attorneys’ fees and expenses subject to court approval.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cc-deadline-alert-levi–korsinsky-reminds-the-chemours-company-cc-investors-of-securities-class-action-deadline-on-december-7-2026-302922600.html

SOURCE Levi & Korsinsky, LLP